Drugs for Common Wart (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 18)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Vaccines |
|
Phase 4 |
|
|
|
2 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
3 |
|
Zinc |
Approved, Investigational |
Phase 3 |
|
7440-66-6 |
32051
|
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
4 |
|
Zinc sulfate |
Approved, Investigational |
Phase 3 |
|
7733-02-0 |
|
Synonyms:
Zinc sulfate (anhydrous)
Zinc sulfate anhydrous
Zinc sulfate, anhydrous
|
Zinc sulphate anhydrous
Zinc sulphate, anhydrous
|
|
5 |
|
Hydrogen peroxide |
Approved, Vet_approved |
Phase 3 |
|
7722-84-1 |
784
|
Synonyms:
[OH(OH)]
Adeka super el
Albone
Albone 35
Albone DS
Anti-keim 50
Asepticper
Baquashock
CIX
Clarigel gold
Crestal whitestrips
Crystacide
Dentasept
Deslime LP
Dihydrogen dioxide
H2O2
Hioxyl
Hipox
HOOH
Hybrite
Hydrogen dioxide
Hydrogen peroxide (H2O2)
Hydroperoxide
Inhibine
Lase peroxide
|
Lensan a
Magic bleaching
Metrokur
Mirasept
Nite white excel 2
Odosat D
Opalescence xtra
Oxigenal
Oxydol
Oxyfull
Oxysept
Oxysept I
Pegasyl
Perhydrol
Perone
Peroxaan
Peroxclean
Peroxide, hydrogen
Quasar brite
Select bleach
Superoxol
T-Stuff
Whiteness HP
Whitespeed
Xtra white
|
|
6 |
|
Ethanol |
Approved |
Phase 3 |
|
64-17-5 |
702
|
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
7 |
|
insulin |
|
Phase 3 |
|
|
|
8 |
|
Insulin, Globin Zinc |
|
Phase 3 |
|
|
|
9 |
|
Nutrients |
|
Phase 3 |
|
|
|
10 |
|
Micronutrients |
|
Phase 3 |
|
|
|
11 |
|
Dermatologic Agents |
|
Phase 3 |
|
|
|
12 |
|
Trace Elements |
|
Phase 3 |
|
|
|
13 |
|
Astringents |
|
Phase 3 |
|
|
|
14 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
15 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
16 |
|
Anti-Infective Agents, Local |
|
Phase 3 |
|
|
|
17 |
|
Central Nervous System Depressants |
|
Phase 3 |
|
|
|
18 |
|
Cantharidin |
Approved, Investigational |
Phase 2 |
|
56-25-7 |
|
Synonyms:
1,2-Dimethyl-3,6-epoxyperhydrophthalic anhydride
Cantharidine
Cantharone
|
exo-1,2-cis-Dimethyl-3,6-epoxyhexahydrophthalic anhydride
Kantharidin
|
|
Interventional clinical trials:
(show all 25)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts : a Randomized Controlled Trial |
Unknown status |
NCT03183765
|
Phase 4 |
Measles-Mumps-Rubella Vaccine |
2 |
Randomized Study to Evaluate 2LVERU® JUNIOR and 2LVERU® on the Treatment of Warts. |
Not yet recruiting |
NCT03977753
|
Phase 4 |
2LVERU® or 2LVERU® JUNIOR |
3 |
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts |
Recruiting |
NCT03687372
|
Phase 3 |
A-101 |
4 |
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts, A Randomized Clinical Trial |
Recruiting |
NCT03158168
|
Phase 3 |
Candida Antigen;Zinc Sulfate |
5 |
A Phase 3 Open Label Safety Study of A-101 Topical Solution for the Treatment of Common Warts |
Active, not recruiting |
NCT03812510
|
Phase 3 |
A-101 |
6 |
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts |
Active, not recruiting |
NCT03691831
|
Phase 3 |
A-101 |
7 |
A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel for the Treatment of Common Warts in Adults |
Completed |
NCT00114920
|
Phase 2 |
Resiquimod |
8 |
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts |
Completed |
NCT03278028
|
Phase 2 |
A-101 Topical Solution;A-101 Vehicle Solution |
9 |
A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Pediatric Subjects |
Completed |
NCT00116675
|
Phase 2 |
Resiquimod |
10 |
A Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Pediatric Subjects |
Completed |
NCT00116662
|
Phase 2 |
Resiquimod |
11 |
A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 3 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults |
Completed |
NCT00115141
|
Phase 2 |
Resiquimod |
12 |
A Three-Stage, Modified-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for 4 Weeks for the Treatment of Common Warts in Adults |
Completed |
NCT00117923
|
Phase 2 |
Resiquimod |
13 |
A Two-Stage, Single-Blind, Dose-Escalating Study to Assess Efficacy and Safety of Resiquimod Gel Applied 5 Times Per Week for up to 12 Weeks for the Treatment of Common Warts in Adults |
Completed |
NCT00117871
|
Phase 2 |
Resiquimod |
14 |
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Solution in Subjects With Common Warts. |
Completed |
NCT02669862
|
Phase 2 |
A-101 Solution 40;A-101 Solution 45;Vehicle Solution |
15 |
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts |
Completed |
NCT03210337
|
Phase 2 |
A-101 Topical Solution;A-101 Vehicle Solution |
16 |
Study of the Safety and Effectiveness of Candin for the Treatment of Common Warts |
Completed |
NCT01757392
|
Phase 2 |
|
17 |
A Phase 2, Open Label Study to Evaluate the Efficacy, Safety and Tolerability of VP-102 in Subjects With Common Warts (Verruca Vulgaris) |
Completed |
NCT03487549
|
Phase 2 |
VP-102-cantharidin topical film forming solution |
18 |
A Double-blind, Randomized, Vehicle-controlled, Parallel-group, Phase II Dose-ranging Study to Evaluate the Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients. |
Suspended |
NCT01796795
|
Phase 2 |
Vehicle gel;SR-T100 gel with 1.0% of SM;SR-T100 gel with 2.3% of SM |
19 |
A Randomized, Placebo-controlled, Double-blind Phase I Study to Explore Safety, Tolerability and Pharmacodynamics of CyPep-1 in Subjects With Cutaneous Warts |
Recruiting |
NCT03846648
|
Phase 1 |
Cypep-1 |
20 |
A Phase I, Single-Centre, Open-Label, Fixed-Dose Study of the Safety and Efficacy of up- to Three-Days Application of 0.05% PEP005 Topical Gel in the Treatment of Patients With Common Wart(s) (Verruca[e] Vulgaris) on the Dorsal Hand |
Withdrawn |
NCT00546611
|
Phase 1 |
PEP005 |
21 |
Comparative Evaluation of Carbon Dioxide Laser and Cryotherapy by Dermoscopy in Treatment of Viral Wart |
Unknown status |
NCT03166137
|
|
|
22 |
Double-Blind, Randomized Control Trial To Evaluate the Efficacy of Duct Tape Versus Placebo for the Treatment of Verruca Vulgaris |
Completed |
NCT00328991
|
|
|
23 |
Nanopulse Efficacy Study for the Treatment of Common Warts |
Completed |
NCT02650466
|
|
|
24 |
Epidemiologic and Molecular Features of Cervical Cancer in Nigeria - Project Itoju (Care) |
Active, not recruiting |
NCT00804466
|
|
|
25 |
Randomized Double Blind Study Comparing Liquid Nitrogen Cryotherapy With Nd:YAG in the Treatment of Verruca Vulgaris |
Terminated |
NCT01609530
|
|
|
|